GlobeNewswire Inc.··Cytomx Therapeutics, Inc.CytomX Raises $250M via Stock Offering to Fund Varseta-M Development
CytomX Therapeutics prices $250M stock offering at $5.30/share to fund Varseta-M development and pipeline advancement, closing March 2026.
AMGNBMYCELGrREGNMRNA+1colorectal cancerpublic offering